-

Innovation Improves Care Delivery Around the World

Allscripts robust patent program earns five new application patents in eight days

CHICAGO--(BUSINESS WIRE)--Allscripts Healthcare Solutions (NASDAQ: MDRX) was recently awarded five separate patents over the course of just eight days, reflecting the company’s commitment to delivering unique solutions to its clients and demonstrating its significant momentum in health IT innovation. The Allscripts patent program is expected to add numerous additional patents throughout the remainder of 2020 as the company will deliver innovation to improve how clinicians deliver care and connect the overall patient experience.

Each of the patents recently awarded contributes to streamlining and improving healthcare delivery. For example, one of the patents is for an application that connects electronic health records (EHRs) to various wellness applications to provide patients frictionless goal-tacking functionality, which directly leads to a higher level of patient engagement. Another application enables API calls from EHRs to initiate searches over genetic testing data stores. A patent was also issued for an application that helps organizations secure data in a HIPAA-compliant manner that will not cause performance issues that are often associated with typical encryption practices.

With a long history as a leader in healthcare technology, Allscripts continues seizing opportunities to enrich its offerings. Through extensive investment in software R&D these efforts have resulted in an extensive patent program that has 150 patents issued plus another 150-plus patents currently pending. In 2013 there was one patent in the Allscripts portfolio. Allscripts’ vision remains firmly set on providing healthcare organizations the distinctive solutions they need to deliver excellent care.

“Innovation is at the core of everything we do and I’m proud of the visionary work our team consistently executes upon to grow the capabilities of our solutions to help our clients deliver better care,” said Allscripts CEO, Paul Black. “Allscripts believes that healthcare solutions should be open, for everyone, and leading-edge innovation is the driver to make that a reality.”

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Contacts

Investors:
Stephen Shulstein
312-386-6735
Stephen.Shulstein@allscripts.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com

Allscripts Healthcare Solutions

NASDAQ:MDRX

Release Versions
Hashtags

Contacts

Investors:
Stephen Shulstein
312-386-6735
Stephen.Shulstein@allscripts.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com

More News From Allscripts Healthcare Solutions

Veradigm Provides Business and Strategy Update

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, is providing estimated financial performance for the fiscal year 2025 and key areas of strategic focus for 2026. “On my first investor call in October, I committed to advancing three strategic objectives in my first 100 days: reset our business strategy, recover our market leadership with independent physician practices and reignite profitable growth,” said...

Veradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey Solution

CHICAGO--(BUSINESS WIRE)--Veradigm (OTCMKTS:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced a new patient‑reported outcomes (PRO) survey capability that brings the patient voice directly into real‑world evidence generation. The new solution gives life sciences organizations timely, privacy‑preserving insights directly from patients, adding essential context to clinical and observational research. Built on Veradigm’s FollowMyHealth pat...

Veradigm to Release Business Update February 17th and Host Investor Call February 18th

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management plans to provide a business update after the close of regular stock market hours on February 17, 2026. Veradigm management plans to host an investor conference call and webcast to discuss the Company’s update at 8:00 a.m. Eastern Time on February 18, 2026. Update Call Details Veradigm plans to issue a press release after the c...
Back to Newsroom